Literature DB >> 18326132

Pre-existing cardiac disease, troponin I elevation and mortality in patients with severe sepsis and septic shock.

E C Scott1, H C Ho, M Yu, A D Chapital, W Koss, D M Takanishi.   

Abstract

A prospective, observational study was undertaken to determine the frequency of troponin I elevation and the incidence of pre-existing cardiac disease in patients with severe sepsis and septic shock, and to determine their relationship to mortality. The setting was the surgical intensive care unit of a tertiary care medical centre. Sixty-six consecutive patients admitted with severe sepsis or septic shock requiring pulmonary artery catheterisation for haemodynamic monitoring were studied. Measurement of troponin I was done at the time of pulmonary artery catheterisation and every six to eight hours if there was ongoing tachycardia, hypotension or arrhythmias requiring treatment. Preexisting cardiac disease was determined from the patient and/or family members as well as from the medical record. Significant cardiac history was defined as prior myocardial infarction; abnormal treadmill report, nuclear medicine study or coronary angiogram; history of congestive heart failure or arrhythmia requiring treatment. Forty-two patients (64%) had elevated troponin I at study entrance and 23 patients (35%) had pre-existing cardiac disease. History of cardiac disease was associated with reduced cardiac index and oxygen delivery, and a nearly three-fold increase in mortality (44% vs. 16%, P = 0.03), irrespective of elevated troponin I levels. Troponin I elevation alone was not associated with increased mortality. We conclude that pre-existing cardiac disease and elevated troponin I are commonly found in surgical patients with severe sepsis and septic shock. In our study, pre-existing cardiac disease, and not troponin I elevation, was associated with increased mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326132     DOI: 10.1177/0310057X0803600109

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  12 in total

1.  Out-of-hospital characteristics and care of patients with severe sepsis: a cohort study.

Authors:  Christopher W Seymour; Roger A Band; Colin R Cooke; Mark E Mikkelsen; Julie Hylton; Tom D Rea; Christopher H Goss; David F Gaieski
Journal:  J Crit Care       Date:  2010-04-08       Impact factor: 3.425

Review 2.  Raised cardiac troponin in intensive care patients with sepsis, in the absence of angiographically documented coronary artery disease: A systematic review.

Authors:  Vasileios Zochios; Kamen Valchanov
Journal:  J Intensive Care Soc       Date:  2014-12-09

Review 3.  [Use of biomarkers in sepsis. Update and perspectives].

Authors:  B H Siegler; S Weiterer; C Lichtenstern; D Stumpp; T Brenner; S Hofer; M A Weigand; F Uhle
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

4.  Elevation of NT-proBNP and cardiac troponins in sepsis-related deaths: a forensic perspective.

Authors:  Camilla Tettamanti; Tania Hervet; Silke Grabherr; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2016-03-22       Impact factor: 2.686

5.  Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome.

Authors:  Helge Røsjø; Marjut Varpula; Tor-Arne Hagve; Sari Karlsson; Esko Ruokonen; Ville Pettilä; Torbjørn Omland
Journal:  Intensive Care Med       Date:  2010-10-12       Impact factor: 17.440

6.  What Demographic and Clinical Factors Are Associated with In-hospital Mortality in Patients with Necrotizing Fasciitis?

Authors:  Jaret Karnuta; Joseph Featherall; Joshua Lawrenz; Jaymeson Gordon; Joshua Golubovsky; Jonah Thomas; Deepak Ramanathan; Claus Simpfendorfer; Lukas M Nystrom; Maja Babic; Nathan W Mesko
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

7.  Impaired vascular function in sepsis-surviving rats mediated by oxidative stress and Rho-Kinase pathway.

Authors:  Priscila de Souza; Karla Lorena Guarido; Karin Scheschowitsch; Luísa Mota da Silva; Maria Fernanda Werner; Jamil Assreuy; José Eduardo da Silva-Santos
Journal:  Redox Biol       Date:  2016-09-30       Impact factor: 11.799

8.  Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine.

Authors:  Sangeeta Mehta; John Granton; Anthony C Gordon; Deborah J Cook; Stephen Lapinsky; Gary Newton; Kris Bandayrel; Anjuli Little; Chuin Siau; Dieter Ayers; Joel Singer; Terry C K Lee; Keith R Walley; Michelle Storms; D James Cooper; Cheryl L Holmes; Paul Hebert; Jeffrey Presneill; James A Russell
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

9.  Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study.

Authors:  Zhi Yang; Aiham Qdaisat; Zhihuang Hu; Elizabeth A Wagar; Cielito Reyes-Gibby; Qing H Meng; Sai-Ching J Yeung
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Chronic dialysis patients with infectious spondylodiscitis have poorer outcomes than non-dialysis populations.

Authors:  George Kuo; Wei-Chiao Sun; Yueh-An Lu; Chao-Yu Chen; Huang-Kai Kao; Yu Lin; Yung-Chang Chen; Cheng-Chieh Hung; Ya-Chung Tian; Hsiang-Hao Hsu
Journal:  Ther Clin Risk Manag       Date:  2018-02-13       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.